4.7 Article

Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 62, 期 -, 页码 597-604

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2013.01.030

关键词

Carbonic anhydrase inhibitors; Benzenesulfonamides; Structure-activity relationship; Molecular docking

资金

  1. Fundamental Research Funds for the Central Universities
  2. National Natural Science Foundation of China [21173076, 81102375, 81222046, 81230090, 81230076]
  3. Shanghai Committee of Science and Technology [11DZ2260600, 10431902600]
  4. Special Fund for Major State Basic Research Project [2009CB918501]
  5. 863 Hi-Tech Program of China [2012AA020308]
  6. Program for New Century Excellent Talents in University [NCET-10-0378]

向作者/读者索取更多资源

In this study, starting from a lead compound discovered by virtual screening, a series of novel hetero-cyclic substituted benzenesulfonamides were designed and synthesized as new carbonic anhydrase IX (CA IX) inhibitors. Some compounds exhibited potent inhibitory effects against CA IX (in the low nanomolar range) as well as high selectivity against other carbonic anhydrase isozymes (CA I and CA II). The most potent and selective compound 27 could inhibit CA IX in the subnanomolar level with IC50 of 0.48 nM, which increased the potency by about 40-fold against CA IX compared with the lead compound 26, and presented more than 10(3) fold selectivity over CA I and CA II. The structure activity relationship (SAR) based on the docking experiments further elucidated the effects of the compounds on the bioactivity and selectivity. (C) 2013 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据